VK-2809 Uses, Dosage, Side Effects and more
VK-2809 is under investigation in clinical trial NCT02927184 (Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease).
| Trade Name | VK-2809 |
| Generic | VK-2809 |
| Type | |
| Formula | C28H32ClO5P |
| Weight | Average: 514.98 Monoisotopic: 514.1675888 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
